Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl

Pediatric Dermatology

Volumn 25, Issue 3, 2008, Pages 387-389

  Cusack, Caitriona ^a   Fitzgerald, Deborah ^a   Clayton, Timothy M ^a   Irvine, Alan D ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; CANTHARONE PLUS; CIDOFOVIR; PODOPHYLLIN; PROBENECID; SALICYLIC ACID; VERRUSOL;

ANAMNESIS; ARTICLE; CASE REPORT; CRYOTHERAPY; CYTOREDUCTIVE SURGERY; DIATHERMY; DRUG TOLERABILITY; FEMALE; FLORID CUTANEOUS WART; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERRUCA VULGARIS;

ANTIVIRAL AGENTS; CHILD; CYTOSINE; FEMALE; HAND; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHEDEMA; PHOSPHONIC ACIDS; SKIN; WARTS;

EID: 44949255357     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00689.x     Document Type: Article

References (14)

1. Larsson PA, Liden S. Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm Venereol 1980 60 : 415 423.
2. Steinberg BM, Gallagher T, Stoler M et al. Persistence and expression of human papilomavirus during interferon therapy. Arch Otolaryngol Head Neck Surg 1988 114 : 27 32.
3. Zabawski EJ Jr., Cockerell CJ. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J Am Acad Dermatol 1998 39 : 741 745.
4. Sterling JC, Kurtz JB. Viral Infections. In : Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of dermatology, 6th edn, Vol. 2. Oxford : Blackwell Science, 1998 : 1031 1045.
5. Tobin AM, Cotter M, Irvine AD et al. Successful treatment of a refractory verruca in a child with acute lymphoblastic leukaemia with topical cidofovir. Br J Dermatol 2005 152 : 386 388.
6. Summary of product characteristics for vistide (Cidofovir). Milton Keynes : Pharmacia, 2003.
7. Ibarra V, Blanco JR, Oteo JA et al. Efficacy of Cidofovir in the treatment of recalcitrant Molloscum Contagiosum in an AIDS patient. Acta Derm Venereol 2000 80 : 315 316.
8. Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 1999 36 : 127 143.
9. Hivnor C, Shepard JW, Shapiro MS et al. Intravenous Cidofovir for recalcitrant verruca vulgaris in the setting of HIV. Arch Dermatol 2004 140 : 13 14.
10. Grone D, Treudler R, de Villiers EM et al. Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome. J Eur Acad Dermatol Venereol 2006 20 : 202 205.
11. Kottke MD, Parker SR. Intravenous ciofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. J Am Acad Dermatol 2006 55 : 533 536.
12. Lalezari JP, Holland GN, Kramer F et al. Randomised controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998 17 : 339 344.
13. Lacy SA, Hitchcock MJ, Lee WA et al. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynmologous monkeys. Toxicol Sci 1998 44 : 97 106.
14. Araya CE, Lew JF, Fennell RS et al. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant 2006 10 : 32 37.